Published in Am J Pathol on May 01, 1998
Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev (2000) 5.53
TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev (2001) 4.68
Nucleolus, ribosomes, and cancer. Am J Pathol (2008) 2.53
A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin. J Cell Biol (2005) 2.27
RNA-polymerase-I-directed rDNA transcription, life and works. Trends Biochem Sci (2005) 2.13
Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc Natl Acad Sci U S A (2000) 1.89
Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PLoS One (2009) 1.60
RNA polymerase III transcripts and the PTB protein are essential for the integrity of the perinucleolar compartment. Mol Biol Cell (2003) 1.30
Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol (1998) 1.19
A step subsequent to preinitiation complex assembly at the ribosomal RNA gene promoter is rate limiting for human RNA polymerase I-dependent transcription. Mol Cell Biol (2001) 1.16
Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene. Am J Pathol (2011) 1.12
Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci U S A (2003) 1.03
Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation. Oncogene (2011) 0.99
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. Oncogene (2014) 0.95
The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status. J Clin Pathol (2004) 0.89
Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells. Evid Based Complement Alternat Med (2013) 0.89
Environmental cues induce a long noncoding RNA-dependent remodeling of the nucleolus. Mol Biol Cell (2013) 0.87
Ubiquitin and ubiquitin-like proteins in the nucleolus: multitasking tools for a ribosome factory. Genes Cancer (2010) 0.86
Conditional inactivation of Upstream Binding Factor reveals its epigenetic functions and the existence of a somatic nucleolar precursor body. PLoS Genet (2014) 0.85
Nucleolus-derived mediators in oncogenic stress response and activation of p53-dependent pathways. Histochem Cell Biol (2016) 0.85
P19ARF and RasV¹² offer opposing regulation of DHX33 translation to dictate tumor cell fate. Mol Cell Biol (2013) 0.84
Nucleolus size variation during meiosis and NOR activity of a B chromosome in the grasshopper Eyprepocnemis plorans. Chromosome Res (2007) 0.84
Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility? Oncotarget (2015) 0.84
Increased expression of a nucleolar Nop5/Sik family member in metastatic melanoma cells: evidence for its role in nucleolar sizing and function. Am J Pathol (2001) 0.83
The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas. BMC Cancer (2014) 0.82
Classification between normal and tumor tissues based on the pair-wise gene expression ratio. BMC Cancer (2004) 0.80
Repressed synthesis of ribosomal proteins generates protein-specific cell cycle and morphological phenotypes. Mol Biol Cell (2013) 0.79
Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival. Proc Natl Acad Sci U S A (2016) 0.79
Overexpression of ribosomal RNA in cumulus cells of patients with polycystic ovary syndrome. J Assist Reprod Genet (2012) 0.78
Wnt5a Signals through DVL1 to Repress Ribosomal DNA Transcription by RNA Polymerase I. PLoS Genet (2016) 0.78
Automated image based prominent nucleoli detection. J Pathol Inform (2015) 0.77
Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart. Cell Death Dis (2011) 0.77
Determinants of mammalian nucleolar architecture. Chromosoma (2015) 0.77
Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells. Oncotarget (2015) 0.77
Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype. Cancer Med (2016) 0.77
Therapeutic interventions to disrupt the protein synthetic machinery in melanoma. Pigment Cell Melanoma Res (2015) 0.75
The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer. Int J Mol Sci (2017) 0.75
The dynamics of the alternatively spliced NOL7 gene products and role in nucleolar architecture. Nucleus (2011) 0.75
Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation. PLoS One (2016) 0.75
Eosinophilic nucleoli. J Oral Maxillofac Pathol (2014) 0.75
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate. Oncotarget (2016) 0.75
Crosstalk between the nucleolus and the DNA damage response. Mol Biosyst (2017) 0.75
Ribosomal DNA copy number amplification and loss in human cancers is linked to tumor genetic context, nucleolus activity, and proliferation. PLoS Genet (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The U3 small nucleolar ribonucleoprotein functions in the first step of preribosomal RNA processing. Cell (1990) 5.39
Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J (1986) 5.31
Eukaryotic DNA topoisomerases: two forms of type I DNA topoisomerases from HeLa cell nuclei. Proc Natl Acad Sci U S A (1981) 3.98
Fibrillarin: a new protein of the nucleolus identified by autoimmune sera. Biol Cell (1985) 3.72
Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine. J Biol Chem (1985) 3.60
Promotion and regulation of ribosomal transcription in eukaryotes by RNA polymerase I. Prog Nucleic Acid Res Mol Biol (1995) 2.39
Measurement of growth and viability of cells in culture. Methods Enzymol (1979) 2.33
Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc Natl Acad Sci U S A (1988) 2.29
Identification of two forms of the RNA polymerase I transcription factor UBF. Proc Natl Acad Sci U S A (1991) 2.04
Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO J (1985) 1.89
Activation of mammalian ribosomal gene transcription requires phosphorylation of the nucleolar transcription factor UBF. Nucleic Acids Res (1995) 1.69
Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest (1990) 1.64
Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor. J Exp Med (1991) 1.63
Human autoantibodies: probes for nucleolus structure and function. Virchows Arch B Cell Pathol Incl Mol Pathol (1987) 1.20
Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues. Mod Pathol (1994) 1.18
Identification of a nucleolin binding site in human topoisomerase I. J Biol Chem (1996) 1.15
Control points in eucaryotic ribosome biogenesis. Biochem Cell Biol (1991) 1.14
The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp Cell Res (1989) 1.11
Amount of the two major Ag-NOR proteins, nucleolin, and protein B23 is cell-cycle dependent. Cytometry (1997) 1.05
RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I. Cancer Res (1996) 1.04
Nucleolin is an Ag-NOR protein; this property is determined by its amino-terminal domain independently of its phosphorylation state. Exp Cell Res (1992) 1.04
The RNA polymerase I transcription factor UBF is the product of a primary response gene. J Biol Chem (1995) 1.00
The Ag-NOR proteins and transcription and duplication of ribosomal genes in mammalian cell nucleoli. Chromosoma (1991) 0.92
Relationship between quantity of silver stained nucleolar organizer regions associated proteins (Ag-NORs) and population doubling time in ten breast cancer cell lines. Pathol Res Pract (1992) 0.91
Computerized histopathologic assessment of malignant potential. II. A practical method for predicting survival following enucleation for uveal melanoma. Cancer (1983) 0.90
Factors affecting the activity of ribonucleic acid polymerase solubilized from rat liver nuclei. Effect on ionic strength, spermine and divalent ions with native and denatured deoxyribonucleic acid. Eur J Biochem (1970) 0.89
The relative prognostic significance of nucleolar morphometry in invasive ductal breast cancer. Histopathology (1985) 0.88
Quantitative changes of the two major AgNOR proteins, nucleolin and protein B23, related to stimulation of rDNA transcription. Exp Cell Res (1995) 0.87
Relationship between interphase AgNOR distribution and nucleolar size in cancer cells. Histochem J (1992) 0.84
Nucleolin and fibrillarin expression in stimulated lymphocytes and differentiating HL-60 cells. A flow cytometric assay. Cell Prolif (1995) 0.83
Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry. Virchows Arch A Pathol Anat Histopathol (1989) 0.83
The use of a basic dye (azure A or toluidine blue) plus a cationic surfactant for selective staining of RNA: a technical and mechanistic study. Stain Technol (1975) 0.79
The vanishing lung. Lab Invest (1995) 0.79
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell (1997) 5.92
Fibrillarin: a new protein of the nucleolus identified by autoimmune sera. Biol Cell (1985) 3.72
Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000; pI, 8.5) rich in NG,NG-dimethylarginine. J Biol Chem (1985) 3.60
Immunological and ultrastructural studies of the nuclear coiled body with autoimmune antibodies. Exp Cell Res (1991) 3.44
Monoclonal autoantibody from a (New Zealand black x New Zealand white)F1 mouse and some human scleroderma sera target an Mr 34,000 nucleolar protein of the U3 RNP particle. Arthritis Rheum (1987) 3.09
Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol (2001) 2.63
Biofilm in implant infections: its production and regulation. Int J Artif Organs (2005) 2.37
Telomere regions in Drosophila share complex DNA sequences with pericentric heterochromatin. Cell (1983) 2.29
Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Natl Acad Sci U S A (1998) 2.21
Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum (1998) 2.19
Association between the nucleolus and the coiled body. J Struct Biol (1991) 2.18
Chondrocyte apoptosis induced by nitric oxide. Am J Pathol (1995) 2.16
Nucleologenesis: U3 snRNA-containing prenucleolar bodies move to sites of active pre-rRNA transcription after mitosis. Mol Biol Cell (1994) 2.07
Nuclear bodies (NBs): a newly "rediscovered" organelle. Exp Cell Res (1992) 1.92
Silver staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23. Chromosoma (1984) 1.88
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia (2009) 1.86
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol (2008) 1.83
Inhibition by ricin of protein synthesis in vitro. Ribosomes as the target of the toxin. Biochem J (1973) 1.72
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Leukemia (2011) 1.67
Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Lab Invest (1990) 1.64
Molecular characterization of two human autoantigens: unique cDNAs encoding 95- and 160-kD proteins of a putative family in the Golgi complex. J Exp Med (1993) 1.64
Nucleologenesis: composition and fate of prenucleolar bodies. Chromosoma (1985) 1.63
Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J Pathol (2000) 1.59
Inhibition by ricin of protein synthesis in vitro. Inhibition of the binding of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 to ribosomes. Biochem J (1975) 1.53
Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med Microbiol Immunol (2001) 1.47
Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas. Ital J Gastroenterol Hepatol (1998) 1.46
Modeccin, the toxin of Adenia digitata. Purification, toxicity and inhibition of protein synthesis in vitro. Biochem J (1978) 1.46
Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ (1998) 1.43
Inhibition by ricin of protein synthesis in vitro: 60 S ribosomal subunit as the target of the toxin. Biochem J (1973) 1.42
Alterations in chromatin conformation are accompanied by reorganization of nonchromatin domains that contain U-snRNP protein p28 and nuclear protein p107. J Cell Biol (1985) 1.37
Inhibition of protein synthesis in vitro by proteins from the seeds of Momordica charantia (bitter pear melon). Biochem J (1980) 1.35
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. Ann Oncol (2009) 1.34
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Br J Cancer (2007) 1.33
The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest (1995) 1.33
Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A (1998) 1.33
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. Leukemia (2011) 1.26
Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience. Cancer (1999) 1.24
Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol (1998) 1.21
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J Pathol (2006) 1.20
Inhibition of protein synthesis by modeccin, the toxin of Modecca digitata. FEBS Lett (1977) 1.20
Slime production and expression of the slime-associated antigen by staphylococcal clinical isolates. J Clin Microbiol (1999) 1.20
Macromolecular domains containing nuclear protein p107 and U-snRNP protein p28: further evidence for an in situ nuclear matrix. Mol Cell Biochem (1986) 1.18
Further evidence that phosphoprotein C23 (110 kD/pI 5.1) is the nucleolar silver staining protein. Exp Cell Res (1984) 1.17
Effect of modeccin on the steps of peptide-chain elongation. Biochem J (1978) 1.17
High-pressure-liquid-chromatographic and fluorimetric methods for the determination of adenine released from ribosomes by ricin and gelonin. Biochem J (1989) 1.17
Effect of alpha-sarcin and ribosome-inactivating proteins on the interaction of elongation factors with ribosomes. Biochem J (1989) 1.16
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. Leukemia (2012) 1.16
N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification. Tumori (1991) 1.16
Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis. J Cell Sci (1993) 1.15
Etiology of implant orthopedic infections: a survey on 1027 clinical isolates. Int J Artif Organs (2005) 1.15
A rapid PCR method for the detection of slime-producing strains of Staphylococcus epidermidis and S. aureus in periprosthesis infections. Diagn Mol Pathol (2001) 1.14
Studies on the proteins from the seeds of Croton tiglium and of Jatropha curcas. Toxic properties and inhibition of protein synthesis in vitro. Biochem J (1976) 1.14
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent. Leukemia (2006) 1.13
aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia. Oncogene (2007) 1.13
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. Oncogene (2011) 1.13
Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum (1997) 1.13
Inhibition of protein synthesis in vitro by crotins and ricin. Effect on the steps of peptide chain elongation. Biochem J (1976) 1.12
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. J Clin Oncol (1997) 1.11
The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp Cell Res (1989) 1.11
Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol (1992) 1.10
Primary endocervical extraosseous Ewing's sarcoma/PNET. Int J Gynecol Pathol (1998) 1.09
A functional in vitro model for studies of intracellular motility in digitonin-permeabilized erythrophores. J Cell Biol (1982) 1.08
Antinuclear autoantibodies in women with silicone breast implants. Lancet (1992) 1.06
Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors. Oncogene (2008) 1.06
Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant (2003) 1.05
Nuclear apoptotic changes: an overview. J Cell Biochem (2001) 1.05
Binding of nicotinamide-adenine dinucleotides to diphtheria toxin. Biochem J (1967) 1.05
Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group. Bone Marrow Transplant (1996) 1.03
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia (2002) 1.03
Implant infection and infection resistant materials: a mini review. Int J Artif Organs (2005) 1.02
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. Leukemia (2011) 1.02
Nucleologenesis: use of non-isotopic in situ hybridization and immunocytochemistry to compare the localization of rDNA and nucleolar proteins during mitosis. Biol Cell (1989) 1.02
Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood (1998) 1.02
Relationship between interphasic nucleolar organizer regions and growth rate in two neuroblastoma cell lines. Am J Pathol (1989) 1.01
Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol (2000) 1.00
Nitric oxide production and apoptosis in cells of the meniscus during experimental osteoarthritis. Arthritis Rheum (1999) 1.00
Emerging Staphylococcus species as new pathogens in implant infections. Int J Artif Organs (2006) 0.99
Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants. Int J Artif Organs (2006) 0.99
Studies on diphtheria toxin. The effect of GTP on the toxin-dependent adenosine diphosphate ribosylation of rat liver aminoacyl transferase. II. Chem Biol Interact (1971) 0.99
Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica. Haematologica (2000) 0.99
Staphylococci in orthopaedic surgical wounds. New Microbiol (2001) 0.99
Immunocytochemistry of the cell nucleus. Electron Microsc Rev (1990) 0.99
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer (2008) 0.98
Bacterial communications in implant infections: a target for an intelligence war. Int J Artif Organs (2007) 0.98
Differential requirement of ATP and extra-ribosomal proteins for ribosome inactivation by eight RNA N-glycosidases. Biochem Biophys Res Commun (1992) 0.98
Relationship between elongation factor I- and elongation factor II- dependent guanosine triphosphatase activities of ribosomes. Inhibition of both activities by ricin. Biochem J (1975) 0.98
Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo). Anticancer Res (1996) 0.98
Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum (2001) 0.97
Polynucleotide: adenosine glycosidase activity of saporin-L1: effect on DNA, RNA and poly(A). Biochem J (1996) 0.97
Effects of metal ions on white blood cells of patients with failed total joint arthroplasties. J Biomed Mater Res (1999) 0.96
The RNA-N-glycosidase activity of Shiga-like toxin I: kinetic parameters of the native and activated toxin. Toxicon (1997) 0.96